Jick H, Derby L E, García Rodríguez L A, Jick S S, Dean A D
Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, MA 02173-5207.
Pharmacotherapy. 1993 May-Jun;13(3):212-7.
We performed a population-based study of over 100,000 users of diclofenac, naproxen, or piroxicam to identify cases of important blood, skin, central nervous system, kidney, pancreas, or pulmonary disorders caused by these drugs. In three cases a causal relation seemed likely; one of hemolytic anemia attributed to diclofenac, one of neutropenia attributed to naproxen, and one of pancreatitis attributed to piroxicam. In 13 additional cases a causal connection seemed unlikely but could not be fully ruled out. We conclude that such illnesses are uncommonly caused by the three agents studied.
我们对超过10万名使用双氯芬酸、萘普生或吡罗昔康的用户进行了一项基于人群的研究,以确定由这些药物引起的重要血液、皮肤、中枢神经系统、肾脏、胰腺或肺部疾病的病例。在3例中,因果关系似乎很可能成立;1例为双氯芬酸所致的溶血性贫血,1例为萘普生所致的中性粒细胞减少症,1例为吡罗昔康所致的胰腺炎。在另外13例中,因果关系似乎不太可能,但不能完全排除。我们得出结论,所研究的这三种药物很少引起此类疾病。